Pharma groups slam US decision to support COVID-19 vaccine patent waivers
Regulatory NewsJoanne S. Eglovitch
BiologicsBiotechnologyNorth AmericaRegulatory Intelligence/PolicyResearch, Design and DevelopmentRegulatory NewsJoanne S. EglovitchBiologicsBiotechnologyNorth AmericaRegulatory Intelligence/PolicyResearch, Design and Development